Roberto A. Mignone - 18 Jun 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Jun 2025, 17:39:16 UTC
Prior SEC filing
09 Jun 2025
Next SEC filing
22 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John G. Saia, as attorney-in-fact for Roberto A. Mignone

Key filing fact

Roberto A. Mignone filed Form 4 for Guardant Health, Inc. (GH) on 20 Jun 2025.

Key facts

  • This page summarizes Roberto A. Mignone's Form 4 filing for Guardant Health, Inc. (GH).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Jun 2025, 17:39.

Change

  • Previous filing in this sequence was filed on 09 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258394 Primary reporting owner

MIGNONE ROBERTO

Relationship
Director
Address
3100 HANOVER STREET, PALO ALTO
Signature
/s/ John G. Saia, as attorney-in-fact for Roberto A. Mignone
Signature date
20 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+6,833
Change %
Price
$0.000000
Shares after
6,833
Date
18 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,833
Exercise price
$50.57
Footnotes
F1
GH transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+4,203
Change %
Price
$0.000000
Shares after
4,203
Date
18 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,203
Exercise price
$0.000000
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.

Footnote F2

The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.

Footnote F3

Not applicable for Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .